CytomX Therapeutics, Inc. (CTMX)
NASDAQ: CTMX · Real-Time Price · USD
3.270
-0.050 (-1.51%)
At close: Jun 25, 2026, 4:00 PM EDT
3.270
0.00 (0.00%)
After-hours: Jun 25, 2026, 4:10 PM EDT
CytomX Therapeutics Market Cap
CytomX Therapeutics has a market cap or net worth of $711.89 million as of June 25, 2026. Its market cap has increased by 227.00% in one year.
Market Cap
711.89M
Enterprise Value
368.04M
1-Year Change
227.00%
Ranking
Category
Stock Price
$3.27
Market Cap Chart
Since October 8, 2015, CytomX Therapeutics's market cap has increased from $7.40M to $711.89M, an increase of 9,520.12%. That is a compound annual growth rate of 53.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 25, 2026 | 711.89M | -1.37% |
| Dec 31, 2025 | 721.80M | 795.53% |
| Dec 31, 2024 | 80.60M | -22.35% |
| Dec 29, 2023 | 103.80M | -1.80% |
| Dec 30, 2022 | 105.70M | -62.58% |
| Dec 31, 2021 | 282.50M | -6.70% |
| Dec 31, 2020 | 302.80M | -19.81% |
| Dec 31, 2019 | 377.60M | -44.44% |
| Dec 31, 2018 | 679.60M | -16.18% |
| Dec 29, 2017 | 810.80M | 102.65% |
| Dec 30, 2016 | 400.10M | -46.78% |
| Dec 31, 2015 | 751.80M | 10,059.46% |
| Oct 8, 2015 | 7.40M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Allogene Therapeutics | 714.47M |
| Relmada Therapeutics | 710.11M |
| Oculis Holding AG | 707.75M |
| Immix Biopharma | 705.49M |
| Climb Bio | 704.30M |
| Tenax Therapeutics | 696.89M |
| Aclaris Therapeutics | 687.15M |
| CorMedix | 674.69M |